MetaCap

Chemed Financial Ratios

NYSE: CHEHealth CareMedical/Nursing ServicesUSD

499.82+1.57 (+0.32%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Chemed ratio analysis

Chemed earned a net margin of 10.5% in FY 2025, down from 12.4% a year earlier. Gross margin was 32.5% compared with a median of 33.7% over the prior 9 years. Return on equity reached 27.1%, meaning Chemed generated 0.27 dollars of profit for every dollar of shareholders' equity.

At the end of FY 2025, CHE traded at 23.1 times earnings; across the 10 fiscal years shown, its year-end P/E ranged from 22.5 to 41.5, with a median of 29.1. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.

Summary generated from market data by MetaCap's automated system. Methodology

Chemed financial ratios (annual)

Chemed annual financial ratios
RatioFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
P/E ratio (at fiscal year end)23.1126.9032.6130.8831.4027.3433.1622.4941.4724.75
Price / sales2.413.313.893.573.884.093.642.482.341.67
Price / book6.237.187.949.5413.309.439.707.477.225.01
Gross margin32.5%35.1%35.3%35.8%36.0%33.7%31.8%31.1%31.0%29.3%
Operating margin13.4%15.1%15.0%16.1%16.0%18.7%13.3%13.7%6.8%11.3%
Net margin10.5%12.4%12.0%11.7%12.6%15.4%11.3%11.5%5.9%6.9%
Free cash flow margin12.9%15.1%12.1%11.8%11.7%20.7%12.8%13.1%5.9%6.1%
Return on equity (ROE)27.1%27.0%24.6%31.3%43.1%35.4%30.3%34.8%18.2%20.7%
Return on assets (ROA)17.2%18.1%16.3%17.3%20.0%22.3%17.3%21.1%10.7%12.4%
Debt / equity———0.120.30—0.120.150.190.21
Current ratio1.051.381.610.920.761.100.730.830.910.99
Revenue growth4.1%7.4%6.1%-0.2%2.9%7.3%8.7%7.0%5.7%2.2%
EPS growth-7.8%10.9%8.5%-1.9%-13.5%46.4%8.8%108.7%-9.6%2.4%

Related